Da Silva Franco, R. J. [UNESP]Curi, P. R. [UNESP]Kohlmann, O. [UNESP]Leite, J. B. [UNESP]Spritzer, N. [UNESP]Lorga, A. M. [UNESP]Salomao, F. A. [UNESP]Ferreira, F. S R [UNESP]Chuster, M. [UNESP]Mion, D. M. [UNESP]Diani, P. A. [UNESP]Simoes, J. D S [UNESP]Bergamo, R. [UNESP]Ribeiro, A. B. [UNESP]2014-05-272014-05-271992-01-01Arquivos Brasileiros de Cardiologia, v. 58, n. 3, p. 237-242, 1992.0066-782Xhttp://hdl.handle.net/11449/64201237-242porcaptoprilhydrochlorothiazidepotassiumadultagedblood pressureclinical articlefemalehumanhypertensionmaleoral drug administrationadolescentbloodclinical trialdrug combinationdrug effectdrug resistancemulticenter studyAdolescentAdultAgedBlood PressureCaptoprilDrug ResistanceDrug Therapy, CombinationEnglish AbstractFemaleHumanHydrochlorothiazideHypertensionMaleMiddle AgePotassiumCAPTOPRIL NA HIPERTENSAO ARTERIAL LEVE E MODERADA RESISTENTE A DIURETICOTERAPIA. ESTUDO MULTICENTRICOCaptopril for the treatment of mild to moderate diuretic resistant hypertension. Multicenter studyArtigoAcesso aberto2-s2.0-00268334482-s2.0-0026833448.pdf7095933557855151